US FDA’s Cancer Drug/Diagnostic Pilot Aims To Close Gap Between Regulation And Clinical Practice

 
• By Sue Sutter
  
Bridging Gap
The FDA wants to narrow the space between regulation and clinical practice. • Source: Shutterstock

More from Regulation

More from Policy & Regulation